Home > Press > Reminder: Arrowhead to Hold 2009 Annual Meeting of Shareholders Today, Thursday, March 26, 2009
Abstract:
Management to Outline 2009 Plan and Objectives; Interactive Live Webcast Available to Shareholders and Prospective Investors
Arrowhead Research Corporation (Nasdaq: ARWR) today reminded its shareholders and prospective investors that its 2009 Annual Meeting of Shareholders will be held today at the Company's headquarters in Pasadena, CA at 10:00 a.m. PT. Following the Meeting, Dr. Christopher Anzalone, Arrowhead's Chief Executive Officer and President, will present the Company's strategic plan and objectives for 2009 starting at 10:30 a.m. PT.
The presentation, followed by an interactive in-person and online question and answer period, will be webcast live beginning at 10:30 a.m. PT. Interested parties should access the webcast via Arrowhead's home page: www.arrowheadresearch.com. Participants are encouraged to submit questions to management via the webcast player. Audio and video replay is expected to be available approximately three hours after the conclusion of the Meeting for those unable to attend the live webcast.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown, capital resources available to us, the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports on Forms 8-K and 8-K/A, our Registration Statement on Form S-3, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
####
About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is seeking to build value for shareholders through the progress of majority owned subsidiaries. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications and minority investments in two privately held nanobiotech companies.
Contacts:
Investor Relations Contact
Sanjay M. Hurry
The Piacente Group
T: 212-481-2050
Copyright © Arrowhead Research Corporation
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
FSU researchers develop new methods to generate and improve magnetism of 2D materials December 13th, 2024
Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion December 13th, 2024
Groundbreaking research unveils unified theory for optical singularities in photonic microstructures December 13th, 2024
Announcements
FSU researchers develop new methods to generate and improve magnetism of 2D materials December 13th, 2024
Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion December 13th, 2024
Groundbreaking research unveils unified theory for optical singularities in photonic microstructures December 13th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||